Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

Similar articles for PubMed (Select 16290002)

1.

The prevalence of HR-HPV DNA in ASC-US Pap smears: A military population study.

Stany MP, Bidus MA, Reed EJ, Kaplan KJ, McHale MT, Rose GS, Elkas JC.

Gynecol Oncol. 2006 Apr;101(1):82-5. Epub 2005 Nov 10.

PMID:
16290002
4.
5.

High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.

Bansal M, Austin RM, Zhao C.

Gynecol Oncol. 2009 Nov;115(2):257-61. doi: 10.1016/j.ygyno.2009.07.010. Epub 2009 Aug 7.

PMID:
19665217
7.

Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.

Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G; HIV-HPV Study Group.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):168-75. doi: 10.1097/QAI.0b013e3181938e63.

PMID:
19131892
8.

Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.

Cibas ES, Hong X, Crum CP, Feldman S.

Gynecol Oncol. 2007 Mar;104(3):702-6. Epub 2006 Dec 5.

PMID:
17150245
10.

Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union.

Syrjänen S, Shabalova I, Petrovichev N, Podistov J, Ivanchenko O, Zakharenko S, Nerovjna R, Kljukina L, Branovskaja M, Juschenko A, Tosi P, Syrjänen K; NIS Cohort Study Group.

Int J STD AIDS. 2005 Mar;16(3):217-23.

PMID:
15835076
11.

Clearance of high-risk human papillomavirus (HPV) DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study).

Syrjänen S, Shabalova IP, Petrovichev N, Kozachenko VP, Zakharova T, Pajanidi A, Podistov JI, Chemeris G, Sozaeva LG, Lipova EV, Tsidaeva I, Ivanchenko OG, Pshepurko AA, Zakharenko S, Nerovjna R, Kljukina LB, Erokhina OA, Branovskaja MF, Nikitina M, Grunberga V, Grunberg A, Juschenko A, Tosi P, Cintorino M, Santopietro R, Syrjänen KJ.

Eur J Obstet Gynecol Reprod Biol. 2005 Apr 1;119(2):219-27.

PMID:
15808384
12.

Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents.

Boardman LA, Stanko C, Weitzen S, Sung CJ.

Obstet Gynecol. 2005 Apr;105(4):741-6.

PMID:
15802399
13.

[The correlation of a positive DNA HPV HR test and genotyping human papilloma viruses with the presence of CIN, in women with cytologic evidence of ASC-US and LSIL].

Bedziński M, Józefiak A, Szczepańska M, Pruski D, Kedzia W, Spaczyński M.

Ginekol Pol. 2008 Jul;79(7):490-3. Polish.

PMID:
18819456
14.

Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results.

Guo M, Lin CY, Gong Y, Cogdell DE, Zhang W, Lin E, Sneige N.

Mod Pathol. 2008 Aug;21(8):1037-43. doi: 10.1038/modpathol.2008.93. Epub 2008 May 23.

15.
17.

Cervical cancer screening program integrating Pap smear and HPV DNA testing: a population-based study.

Chao A, Hsu KH, Lai CH, Huang HJ, Hsueh S, Lin SR, Jung SM, Chao FY, Huang SL, Huang CC, Yang JE, Chang TC.

Int J Cancer. 2008 Jun 15;122(12):2835-41. doi: 10.1002/ijc.23441.

PMID:
18338752
19.

[Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].

Guo YL, You K, Geng L, Zhang XW, Shen XY, Yao YJ, Fan XH.

Beijing Da Xue Xue Bao. 2006 Oct 18;38(5):480-2. Chinese.

20.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

PMID:
16978225
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk